Health-Related Quality of Life (HRQOL) Ron D. Hays, Ph.D. UCLA Division of General Internal Medicine and Health Services.

Slides:



Advertisements
Similar presentations
Raptiva™ (efalizumab) Plaque Psoriasis: The Unmet Need
Advertisements

15-minute Introduction to PROMIS Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research Roundtable Meeting on Measuring.
Why Patient-Reported Outcomes Are Important: Growing Implications and Applications for Rheumatologists Ron D. Hays, Ph.D. UCLA Department of Medicine RAND.
1 5/21/2015 Cigarette Smoking and Health-Related Quality of Life in Medicare Beneficiaries Ron D. Hays ISOQOL October 13, 2007.
Case management for multimorbid patients Nathalie Versnel, MSc. François Schellevis, MD, PhD Giel Nijpels, MD, PhD Caroline Baan, PhD.
Cross-Cultural Use of Measurements: Development of the Chinese SF-36 Health Survey Xinhua S. Ren, Ph.D. Boston University School of Public Health, Boston,
1 8/14/2015 Evaluating the Significance of Health-Related Quality of Life Change in Individual Patients Ron Hays October 8, 2004 UCLA GIM/HSR.
1 Health-Related Quality of Life Ron D. Hays, Ph.D. - UCLA Department of Medicine: Division of General Internal Medicine.
Performance of PROMIS® CATs Versus Short forms in Detecting Change Ron D. Hays October 3, 2011 International Association for Computer.
Primer on Evaluating Reliability and Validity of Multi-Item Scales Questionnaire Design and Testing Workshop October 25, 2013, 3:30-5:00pm Wilshire.
Measuring AgrAbility Outcomes with Quality of Life Indicators Robert A. Wilson, Ph.D., M.Sc. University of Delaware Center for Applied Demography and Survey.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Basic Methods for Measurement of Patient-Reported Outcome Measures Ron D. Hays, Ph.D. UCLA/RAND ISOQOL Conference on.
1 9/8/2015 Health-Related Quality of Life Assessment in Outcome Studies Ron D. Hays, Ph.D. UCLA GIM & HSR July 17, 2006 (8:00-9:30 am) Gonda Building Conference.
 Course materials copyrighted 2003 by Ron D. Hays Measurement of Health-Related Quality of Life Outcomes Ron D. Hays, Ph.D. January 29,
1 9/14/2015 Options for Summarizing the SF-36 Health Survey in Health-Related Quality of Life Research Ron D. Hays, Ph.D. NCI, March 29, 2007 (11:00-11:59.
A Comprehensive Approach to the Measurement of Health Outcomes Ron D. Hays, Ph.D. UCLA Department of Medicine November 25, 2008 K30 Track II Module Gonda.
Is the Minimally Important Difference Really 0.50 of a Standard Deviation? Ron D. Hays, Ph.D. June 18, 2004.
Profile Health-Related Quality of Life Measures
PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Joseph Finkelstein, MD, PhD, MA, CCRP ICTR Clinical Registry Workshop, 10 November 2010.
Quality of Life in People with and at Risk for Type 2 Diabetes: Findings from the Study to Help Improve Early Evaluation and Management of Risk Factors.
Responding to Reviews of Submitted Manuscripts Ron D. Hays, Ph.D. UCLA GIM & HSR March 2, 2015 HPM 214, Los Angeles, CA.
Use of Health-Related Quality of Life Measures to Assess Individual Patients July 24, 2014 (1:00 – 2:00 PDT) Kaiser Permanente Methods Webinar Series Ron.
Health-Related Quality of Life as an Indicator of Quality of Care May 4, 2014 (8:30 – 11:30 PDT) HPM216: Quality Assessment/ Making the Business Case for.
1 10/12/2015 Health-Related Quality of Life Assessment Health-Related Quality of Life Assessment Ron D. Hays, Ph.D. November 27, 2002 (8:30-9:30.
Measures Preference-Based Measures Ron D. Hays, Ph.D. February 9, 2004.
1 Lecture #1 Introduction to Outcomes and Effectiveness Research January 5, 2015 (9:00-11:50 am) HPM 214
1 Assessing the Minimally Important Difference in Health-Related Quality of Life Scores Ron D. Hays, Ph.D. UCLA Department of Medicine October 25, 2006,
1 10/19/2015  Course materials copyrighted 2003 by Ron D. Hays A Comprehensive Approach to the Measurement of Health Outcomes Ron D. Hays, Ph.D. UCLA.
1 10/20/2015 Quality of Life in Health Outcome Studies Ron D. Hays, Ph.D. UCLA GIM & HSR November 21, 2006 (9--10:20 am) Room
Measuring Health-Related Quality of Life Ron D. Hays, Ph.D. UCLA Department of Medicine RAND Health Program UCLA Fielding School of Public Health
Development of Physical and Mental Health Summary Scores from PROMIS Global Items Ron D. Hays ( ) UCLA Department of Medicine
A Comprehensive Approach to the Measurement of Health Outcomes Ron D. Hays, Ph.D. UCLA Division of General Internal Medicine.
Measuring Health-Related Quality of Life
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
Introductory Statistics Options, Spring 2008 Stat 100: MWF, 11:00 Science Center C. Stat 100: MWF, 11:00 Science Center C. –General intro to statistical.
1 Health-Related Quality of Life Assessment as an Indicator of Quality of Care (HPM 216) Ron D. Hays April 11, 2013(8:30-11:30 am) Wilshire Blvd.
Health-Related Quality of Life Preference Measures for Vision Studies Ron D. Hays, Ph.D. UCLA GIM & HSR June 10, 2009 (2:30-4:00 pm) Irvine, CA.
1 Session 6 Minimally Important Differences Dave Cella Dennis Revicki Jeff Sloan David Feeny Ron Hays.
1 12/3/2015 Measuring Self-Reported Health Ron D. Hays, Ph.D. UCLA GIM & HSR November 27, 2007 (9:00-10:00 am) Gonda Building (Room 1357)
Do continuity and co-ordination of care influence quality of care and health outcomes? Stephen Campbell, David Reeves, Elizabeth Middleton, Martin Roland.
1 12/18/2015 Comprehensive Approach to Measuring Health Outcomes Ron D. Hays, Ph.D. UCLA GIM & HSR October 23, 2006 (3:15-4:45 pm) MacDonald.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
1 1/5/2016  Course materials copyrighted 2002 by Ron D. Hays Health-Related Quality of Life Assessment Ron D. Hays, Ph.D. February 13,
Psychometric Evaluation of Questionnaire Design and Testing Workshop December , 10:00-11:30 am Wilshire Suite 710 DATA.
Approaches for Estimating Minimally Important Differences Ron D. Hays, Ph.D. January 12, 2004 (8:50-9:10am) Minimal Clinically Important Differences in.
Measurement of Outcomes Ron D. Hays Accelerating eXcellence In translational Science (AXIS) January 17, 2013 (2:00-3:00 pm) 1720 E. 120 th Street, L.A.,
1 2/13/2016 Health-Related Quality of Life Assessment as an Indicator of Quality of Care Ron D. Hays, Ph.D. HS249F January 30, 2008 (3:30-6:30 pm) RAND.
Considerations in Comparing Groups of People with PROs Ron D. Hays, Ph.D. UCLA Department of Medicine May 6, 2008, 3:45-5:00pm ISPOR, Toronto, Canada.
? What more will it take to turn the tide of treatment for angina patients from a PCI-first to an optimal medical therapy– first approach? 1.
Patient-Reported Physical Functioning Ron D. Hays November 27, 2012 (11:15-11:30) UCLA Department of Medicine MCID for Orthopaedic Devices Silver Springs,
Reader’s Digest Introduction to Health-Related Quality of Life Ron D. Hays, Ph.D. UCLA Department of Medicine April 25, 2008 (Signature Grand) Nova Southeastern.
Health-Related Quality of Life in Outcome Studies Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research GCRC Summer Session.
Health-Related Quality of Life (HRQOL) Assessment in Outcome Studies Ron D. Hays, Ph.D. UCLA/RAND GCRC Summer Course “The.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Occluded Artery Trial: 1° Hypothesis and Design 1° Hypothesis: Late PCI to open occluded IRA will ↓ death/reinfarction/class IV CHF by 25% compared to.
The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.
Total Occlusion Study of Canada (TOSCA-2) Trial
Psychometric Evaluation of Items Ron D. Hays
UCLA CMORE Lecture Series
Health-Related Quality of Life Assessment in Outcome Studies
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
TUXEDO–India Trial design: Patients with type 2 diabetes mellitus (DM2) and coronary artery disease undergoing PCI were randomized to receive Taxus Element.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Health-Related Quality of Life Measures (HS249T: Decision Analysis and Cost-Effectiveness Analysis) Ron D. Hays, Ph.D. UCLA Division.
Health-Related Quality of Life as an indicator of Quality of Care
How to Measure Quality of Life
Patient-reported Outcome Measures
Presentation transcript:

Health-Related Quality of Life (HRQOL) Ron D. Hays, Ph.D. UCLA Division of General Internal Medicine and Health Services Research, Department of Medicine UCLA Nursing School Students Factor Building Room 4145 (July 20, 2009, 10:30-11:30 am)

Recent HRQOL Publications Urology Jul 7. [Epub ahead of print], Responsiveness of the University of California-Los Angeles Prostate Cancer Index. Bergman J, Saigal CS, Kwan L, Litwin MS.Bergman JSaigal CSKwan L Litwin MS Arch Intern Med Jun 22;169(12): The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ.Clement FMKlarenbach S Tonelli MJohnson JAManns BJ

Recent HRQOL Publications J Natl Cancer Inst Jun 16;101(12): Epub 2009 Jun 9. Impact of cancer on health- related quality of life of older Americans. Reeve BB, Potosky AL, Smith AW, Han PK, Hays RD, Davis WW, Arora NK, Haffer SC, Clauser SB. Reeve BBPotosky ALSmith AWHan PK Hays RDDavis WWArora NKHaffer SC Clauser SB N Engl J Med Feb 19;360(8): Quality of life after late invasive therapy for occluded arteries. Mark DB, Pan W, Clapp- Channing NE, Anstrom KJ, Ross JR, Fox RS, Devlin GP, Martin CE, Adlbrecht C, Cowper PA, Ray LD, Cohen EA, Lamas GA, Hochman JS; Occluded Artery Trial Investigators.Mark DBPan WClapp- Channing NEAnstrom KJRoss JRFox RS Devlin GPMartin CEAdlbrecht CCowper PARay LDCohen EALamas GAHochman JSOccluded Artery Trial Investigators

Process Of Care Health Outcomes Biological HRQOL ( self-reported ) Technical (consensus) Interpersonal (self-reported) HRQOL is a Patient-Reported Outcome (PRO)

Process of Care Technical Quality (expert consensus) –Quality of Care “If Then” Indicators % of patients with diabetes with one or more HbA1c tests annually Interpersonal Quality (patient reports) –In the last 12 months, how often did your doctor explain things in a way that was easy to understand?

Health Outcomes Biological –% of patients with diabetes with most recent HbA1c level >9.0% ( poor control) HRQOL –In general, would you say that your health is: Excellent Very good Good Fair Poor

Process Of Care Health Outcomes BiologicalHRQOL Technical Quality Interpersonal Quality Patient Behavior Patient Characteristics

Health Services Research 2008 Eisenberg Award

Health-Related Quality of Life is: How the person FEELs (well-being) Emotional well-being Pain Energy What the person can DO (functioning) Self-care Role Social

HRQOL is Not Quality of environment Type of housing Level of income Social Support

Greater % of fair or poor health reported by older adults (33% for 75+ versus 9% for 18-34)

In general, how would you rate your health? Poor Fair Good Very Good Excellent

Does your health now limit you in walking more than a mile? (If so, how much?) No, not limited at all Yes, limited a little Yes, limited a lot

How much of the time during the past 4 weeks have you been happy? None of the time A little of the time Some of the time Most of the time All of the time

X = (original score - minimum) * Scoring of HRQOL Scales (maximum - minimum) Average or sum all items in the same scale. 0 (worst) to 100 (best) possible range (linear) transformation

The following items are about activities you might do during a typical day. Does your health now limit you in these activities? If so, how much? 1.Yes, limited a lot > 0 2.Yes, limited a little ----> 50 3.No, not limited at all -->100 1.Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports 2.Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf 3.Lifting or carrying groceries 4.Climbing several flights of stairs 5.Climbing one flight of stairs 6.Bending, kneeling, or stooping 7.Walking more than a mile 8.Walking several blocks 9.Walking one block 10.Bathing or dressing yourself

Change in Physical Function My score today = 100 Event #1: -Hit by Rock results in being limited a little in vigorous activities -Post-intervention score: 95 ( SD) Event #2: -Hit by Bike results in me being: - limited a lot in vigorous activities and in climbing several flights of stairs - limited a little in moderate activities -Post-intervention score: 75 ( SD) Mean = 87 (SD =  20) 75th percentile = 100 (U.S. males)

% Dead (n=676) (n=754) (n=1181) (n=609) SF-36 Physical Health Component Score (PCS)—T score Ware et al. (1994). SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Self-Reported Physical Health Predictive of 5-Year Mortality

Is New Treatment (X) Better Than Standard Care (O)? X 0 X 0 PhysicalFunction X > 0 MentalHealth 0 > X 0X Social Health 0 > X 0 > X

Medicine Use Diminishes HRQOL? dead 1 Nodead dead 2 Nodead 3 No50 4 No75 5 No100 6 Yes0 7 Yes25 8 Yes50 9 Yes75 10 Yes100 Medication Person Use HRQOL (0-100 scale) No Medicine375 Yes Medicine550 Group n HRQOL

Perfect Health Bad as being dead Preference-based HRQOL Measure Yields Summary Score

Preference-Based HRQOL Measures Cost  Effectiveness 

Quality of Life after Late Invasive Therapy for Occluded Arteries Patients with totally occluded infarct- related artery 3-28 days after MI Randomized to: –Medical therapy alone (n = 474) –Percutaneous coronary intervention (PCI) plus stenting (n = 477) Primary outcome—composite of death, reinfarction, or hospital treatment for class IV heart failure

Health-Related Quality of Life Outcome Measures (baseline, 4, 12 & 24 months) Duke Activity Status Index (DASI) Medical Outcomes Study 36-Item Short- Form (SF-36) Mental Health Scale (MHI-5) Time tradeoff (TTO)

DASI Self-administered questionnaire measuring physical functioning (designed to estimate peak oxygen uptake). –Can you run a short distance? –Can you do yard work like raking leaves weeding or pushing a power mower? 0-58 score range (higher is better), >=4 is “clinically significant”

MHI-5 How much of the time during the past 4 weeks: –Have you been a very nervous person? –Have you felt so down in the dumps that nothing could cheer you up? –Have you felt calm and peaceful? –Have you felt down-hearted and blue? –Have you been a happy person? score range (higher is better), >=5 is “clinically significant”

Cardiac Symptoms Rose –Angina questionnaire (7 questions) Chest pain and whether provoked by walking and relieved by rest –Dyspnea questionnaire (4 questions)

Choice #1: Your present state Life Expectancy: 10 years Choice #2: Excellent health How many years (x) would you give up in your current state to be able to have complete mobility? [ 1 - X = QALY ] 10 TTO

How many years (x) would you give up in your current state to be able to have excellent health? X = 0  QALY = 1 X = 1 -> QALY = 0.9 X = 5 -> QALY = 0.5 X = 10 -> QALY = 0 [ 1 - X = QALY ] 10 TTO Estimates

Results & Conclusions 2-year net cost was $7,089 for PCI DAI at 4 months –PCI (37) versus Medical therapy (33) 2-year QALYs –1.42 vs.1.45 for PCI and Medical therapy Does not support common practice of routine PCI in patients in stable condition after MI with occluded infarct-related artery.